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Background: Avoidable mortality (AM), or “unnecessary untimely death,” is considered an indicator of health care
quality. We investigated trends in the age-standardized mortality rates (ASMRs) and associated standard expected
years of life lost (SEYLL) for deaths amenable to medical care or public health measures in Taiwan from 1971-2008,
with an emphasis on identifying areas where additional medical or public health investment may help reduce the
burden of AM.
Methods: Taiwan’s ASMRs per 100,000 for AM and other causes of death were calculated using data from the
National Death Certificate Registry in five-year bins from 1971 to 2008. SEYLL rates per 100,000 were calculated
annually from 1971 to 2008 using the same data source.
Results: ASMR for almost all AM and other causes of death declined dramatically from 1971 to 2008 except for
lung cancer (16.6% and 7.4% increase among men and women, respectively) and breast cancer (109.8% increase
among women). In the same period, SEYLL due to lung cancer increased from 269.2 to 555.7 for men and 249.7 to
342.5 for women. For women, SEYLL due to breast cancer increased from 263.5 in 1971 to 659.3 in 2008. There
were gender-specific differences in the reduction (or increase) in AM rates, with women showing larger rates of
reduction or smaller rates of increase. Among men, AM fell by 65.9% from 1971-1975 to 2006-2008, and deaths
from other causes increased by 15.6%. Among women, AM and deaths from other causes fell by 80.8% and 59.8%
respectively. SEYLL decreased, respectively among males and females, from 23,147.3 and 24,081.1 in 1971 to
11,261.8 and 5,929.6 in 2008.
Conclusion: From 1971 to 2008, Taiwan experienced a dramatic reduction in most AM and corresponding SEYLL
except for lung cancer (for both males and females) and breast cancer (for females). Additional effort should be
devoted to public health measures to combat the rising prevalence of smoking in Taiwan, which may be
responsible for the increasing AM from lung cancer. If AM in breast cancer continues unabated in the future,
greater policy emphasis on the early detection and treatment of breast cancer may also be warranted.
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Avoidable mortality (AM), or “unnecessary untimely
deaths” that could have been prevented with appropriate
medical care or public health measures, is considered an
indicator of health care quality [1]. Temporal trend stud-
ies documented that AM generally fell faster than other
causes of death during the last few decades in the West
[2-5]. Mackenbach and colleagues, in particular, demon-
strated that reductions in AM often followed introduc-
tion of effective treatments for the associated medical
conditions [3]. As a whole, the literature credits the in-
creases in health services effectiveness for much of the
decline in avoidable deaths in Western countries [3,5,6].
Nevertheless, few studies have investigated the trend in
AM in Asian countries, which together represent over
60% of world population [7].
The primary aims of this study were twofold. First, we
documented the temporal trends in AM and associated
changes in standard expected years of life lost (SEYLL)
in Taiwan from 1971 to 2008. Second, we identified spe-
cific disease categories where additional medical or pub-
lic health investment may be warranted given their
unsatisfactory AM trends.
Studies linking reductions in AM with access to care or
socioeconomic status have been widely conducted since
the 1970s in North America and Europe [5,6,8-20]. Only a
few studies, however, investigated the trend in AM in
Asian populations. A Korean study revealed that AM gen-
erally declined from 1983 to 2004, with the exception of
ischemic heart disease and several forms of malignant
neoplasms (lung, breast, and cervix) [21]. Another com-
pared the age-standardized avoidable mortality rates and
proportions in four cities around the world, and found
that Hong Kong had the highest rates in AM from cere-
brovascular disease [22]. In Taiwan, Lee and colleagues
[23] argued that the introduction of National Health In-
surance (NHI) accelerated the decline of AM, particularly
among the young and the elderly, populations unlikely to
have been insured under the previous employment-based
health insurance regime. No study, however, has docu-
mented the temporal trends in AM by individual disease
categories in Taiwan. Our study fills this void in the litera-
ture in order to identify areas for further medical or public
health investment to reduce the burden of AM in Taiwan.
Methods
We obtained mortality data from the Taiwan National
Death Certification Registry between 1971 and 2008.
The population-based registry contains data elements in-
cluding gender, year of birth, and the date and cause of
death for all residents of Taiwan. According to Taiwan
law, a death certificate must be issued and registered
within 30 days after the death of a resident. Trained
medical registrars review and code all death certificatesin the central office of the National Death Certification
Registry. As a result, cause-of-death coding is considered
very accurate in Taiwan [24]. To categorize deaths into
“avoidable deaths” and “deaths due to other causes,” we
followed the definition established by the Concerted
Action of the European Community on Avoidable Mor-
tality (CAEC) [25,26]. The CAEC built on the work
pioneered by Charlton and colleagues [2], which identi-
fied deaths that were thought to be amenable to public
health policy programs as well as a wide array of health
services, such as primary care and hospital services. As
in James and colleagues [27], we considered all AM, in-
cluding those amenable to medical care, those amenable
to public health, and those amenable to both.
Such “untimely unnecessary deaths” include, for ex-
ample, deaths from ischemic heart disease (IHD). These
deaths can be prevented or delayed though public health
interventions such as smoking cessation programs [28,29]
or through medical interventions such as prescription
drugs [30] or surgical procedures [31]. Untimely deaths
from several forms of malignant neoplasms, including
breast, cervical, and uterine cancers can be avoided
through screening and treated with radiation therapy, sur-
gery or chemotherapy [32-34]. The two principal categor-
ies of AM primarily amenable to public health programs
are lung cancer and accidental injuries, the former
through smoking cessation initiatives [35] and the latter
through safety legislation [36]. The list of these amenable
deaths is reproduced in Table 1.
Because our data span nearly four decades, we restricted
our analyses to AM occurring at age 65 or under despite
the considerable advances in life expectancy in Taiwan.
Deaths in Taiwan between 1971 and 2008 not due to AM
were classified as “deaths from other causes.” The num-
bers of AM and other deaths sum to the number of all-
cause deaths. Several variations exist on the definition of
AM, including a more recent 2004 update [37]. However,
given the length of the study period, we selected the 1997
CAEC list of AM as the basis for our analysis.
Trends in age-standardized all-cause mortalities, AM,
and deaths due to other causes were separated into five-
year bins beginning in 1971, except the last bin (2006-
2008). Separate analyses were conducted for males and
females because some medical conditions (such as breast
cancer or cervical cancer) are gender-specific, and others
may have differential outcomes based on an individual’s
gender (such as cerebrovascular diseases [38] or traffic-
related deaths [39]). Age-standardized mortality rates
(ASMRs) per 100,000 individuals were calculated using





Table 1 Selected avoidable deaths
Cause of death Intervention ICD9 code Age-groups
Deaths amenable to both medical care
and public health
001-999 0-64
Ischemic heart disease Public health 410-414, 429.2 35-64
Smoking cessation, lifestyle modification
Medical care
Pharmacotherapy, angioplasty, surgery
Deaths amenable to medical care
Tuberculosis Immunization, contact tracing,
pharmacotherapy
010-018, 137 5-64
Malignant neoplasm of the breast [breast
cancer]
Screening, surgery, radiation therapy,
chemotherapy
174 25-64
Malignant neoplasm of the cervix uteri
[cervical cancer]
Screening, surgery, radiation therapy,
chemotherapy
180 15-64
Malignant neoplasm of the uterus [uterine
cancer]
Screening, surgery, radiation therapy,
chemotherapy
179, 182 15-64
Hodgkin's disease Chemotherapy, radiation therapy, 201 15-64
Hypertension and cerebrovascular disease Pharmacotherapy, carotid endarterectomy 401-405, 430-438 35-64
Asthma Pharmacotherapy 493 5-44
Gastric and duodenal ulcer [ulcers] Pharmacotherapy, surgery 531-534 25-64
Appendicitis Surgery 540-543 5-64
Hernia Surgery 550-553 5-64
Cholelithiasis, cholecystitis and cholangitis
[Gallbladder diseases]
Pharmacotherapy, surgery 575-476 5-64
Complications of pregnancy [Maternal
mortality]
Pharmacotherapy, surgery 630-676 0-64
Perinatal conditions Screening, pharmacotherapy, surgery 760-779 > 28 weeks, gestation < 1 week
and stillbirths
Deaths amenable to public health
Malignant neoplasm of the trachea,
bronchus and lung [Lung cancer]
Smoking cessation, lifestyle modification 162 35-64
Accidents/Poisonings/Violence [Injuries] Legislation, safety equipment 800-999 0-64
Adapted from the European Community Working Group on Health Services and Avoidable Deaths, 1997 and reproduced from James et al [27].
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reference population (the world population in 2000) and
Ai is the age-specific mortality rate in the ith age class in
Taiwan.
Standard expected years of life lost (SEYLL) were cal-







where Ei is the 2008 life expectancy in Taiwan for the
mid-age of age group i, di is the number of deaths from
the cause in the age group i, pi is the number of people
in the examined population age group i, PRi is the num-
ber of people in the 2000 world reference population age
group i, and NR is the number of people in the reference
population under 75 years of age.We present all ASMR and SEYLL values, and compare
gender differences without confidence intervals or statis-
tical tests because our data include the entire population
of all deaths in Taiwan from the National Death Certifi-
cation Registry.
Results
The temporal changes in AM amenable to medical care,
public health, and other causes of death are presented
graphically in Figure 1a and b for men and women, re-
spectively. In Figure 2a and b, AM trends are shown for
four diseases that either experienced the greatest reduc-
tions in AM (hypertension/cerebrovascular disease and
injuries) or increased during the study period (lung
cancer for both men and women, and breast cancer for
women). Equivalent figures expressed in SEYLL rates are
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Figure 1 Deaths amenable to public health, deaths amenable to medical care, and unavoidable deaths from 1971 to 2008 (a: males,
b: females).
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cluding the trends in all-cause mortalities, AM, and
deaths due to other causes in five-year increments (ex-
cept the last three years) from 1971 to 2008, for males
and females respectively. Annual SEYLL rates from 1971
to 2008 are presented in the Additional file 3 for males
and Additional file 4 for females. The ASMRs for all but
two amenable deaths followed a consistent trend down-
ward during the 38-year study period. The only infectious
disease on the list of AM, tuberculosis, experienced dra-
matic reductions from 50.3 (7.4% of all deaths for males)
and 25.4 (4.3% for females) per 100,000 in 1971-1975 to
1.4 (0.3%) and 0.3 (0.2%) in 2006-2008 respectively. In
fact, among men, tuberculosis demonstrated one of the
largest reductions (100%) in ASMR during the study
period. SEYLL due to tuberculosis dropped from 1,478.3
in 1971 to 40.0 in 2008. Among women, the reduction
in AM due to tuberculosis was also dramatic (98.8%),
with the corresponding SEYLL falling from 1,020.8 in
1971 to 12.5 in 2008.
AM with the greatest reductions
In terms of the absolute number of ASMR reductions,
deaths from hypertension and cerebrovascular diseases
dropped from 319.9 per 100,000 (47.2% of all deaths) in1971-1975 to 59.4 per 100,000 (18.8% of all deaths) in
2006-2008, a fall of 81.4% among men. SEYLL due to
hypertension and cerebrovascular disease among men
dropped from 7,586.2 in 1971 to 1,920.8 in 2008. Among
women, AM from hypertension and cerebrovascular dis-
eases also witnessed significant reductions – from 345.1
per 100,000 (57.9% of all deaths) to 21.7 per 100,000
(16.6% of all deaths), or a decline of 93.7%. For women,
SEYLL for hypertension-related diseases also fell notice-
ably from 9,774.5 in 1971 to 966.3 in 2008. The ASMR
for ischemic heart disease also (IHD) also fell for both
men and women, but there were noticeable disparities
between the sexes. The IHD ASMR dropped from 36.7
per 100,000 (5.4% of all deaths) to 30.6 per 100,000 (9.7%
of all deaths) for men, a reduction of 16.6%. Among men,
although the ASMR for IHD fell during this period, con-
comitant with a rise in the proportion of deaths due to
IHD, SEYLL due to IHD increased from 767.4 in 1971 to
989.8 in 2008. For women, however, the change was far
more dramatic. From 31.3 per 100,000 (5.3% of all deaths),
the IHD ASMR plunged to 7.8 per 100,000 (6.0% of all
deaths), a decline of nearly 75.1%. Among women, IHD
SEYLL declined from 841.2 in 1971 to 379.9 in 2008. For
both sexes, even as the ASMRs declined, the proportion
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Figure 2 Deaths due to lung cancer, hypertension/cerebrovascular disease, and injuries, 1971-2008 (a: males, b: females).
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clines in ASMRs and significant differences between the
sexes. In almost every single period, the ASMR due to
injuries for men was more than twice that for women.
In 1971-1975, 99.6 per 100,000 men died from injuries
(14.7% of all deaths), and 40.1 per 100,000 women (6.7%
of all deaths) lost their lives from injuries. The reduction
in injury-related ASMRs over the nearly four-decade
study period was 37.7% for men, and 45.9% per women.
SEYLL rates for both men and women declined, respect-
ively, from 3,933.7 and 1,823.6 in 1971 to 2,194.0 and
901.8 in 2008.
Other AM that experienced large reductions in per-
centage terms include ulcers (93.4% reduction for men,
96.8% for women), hernia (100% reduction for men,
100% for women), appendicitis (100% reduction for
men, 100% for women), asthma (87.2% reduction for
men, 96.3% for women), Hodgkin’s disease (66.7% reduc-
tion for men, 100% for women), and gallbladder disease(72.2% reduction for men, 88.2% for women). AM with re-
ductions of 100% are a result of rounding, signifying that
mortality from these causes is virtually nil at the popula-
tion (aged 65 and under) level by 2006-2008.
AM that experienced increases
The only two categories of AM that countered the con-
tinual decline in ASMRs throughout the period were
deaths due to lung cancer (for both men and women)
and to breast cancer (for women only). Lung cancer
ASMRs grew from 33.8 per 100,000 (5.0% of all deaths)
among men in 1971-1975 to 39.4 per 100,000 (12.5% of
all deaths) in 2006-2008, an increase of 16.6%. SEYLL
from lung cancer doubled, from 269.2 in 1971 to 555.7
in 2008 among men. For women, the increase was
smaller, but still in the high single digits at 7.4%, from
20.3 per 100,000 (3.4% of all deaths) to 21.8 per 100,000
(16.7% of all deaths). SEYLL likewise increased, from
249.7 in 1971 to 342.5 in 2008 among women. The
Table 2 All-cause mortality under 65 years and “avoidable” mortality in Taiwan from 1971 to 2008, males
Cause 1971~1975 1976~1980 1981~1985 1986~1990 1991~1995 1996~2000 2001~2005 2006~2008 %
changeASMR % ASMR % ASMR % ASMR % ASMR % ASMR % ASMR % ASMR %
All causes 677.4 100 629.5 100 461.7 100 362.2 100 339.8 100 323.4 100 332.4 100 315.6 100 53.4
Injuries 99.6 14.7 110.9 17.6 106.1 23 104.9 29 94.5 27.8 81.2 25.1 70.6 21.2 62.1 19.7 37.7
Ischemic heart disease 36.7 5.4 43.8 7 33.6 7.3 29.3 8.1 32.5 9.6 28.7 8.9 33.6 10.1 30.6 9.7 16.6




319.9 47.2 311.6 49.5 192.3 41.7 110.6 30.5 87.5 25.8 68.7 21.2 65.7 19.8 59.4 18.8 81.4
Ulcers 27.3 4 16 2.5 7.9 1.7 3.5 1 3.1 0.9 2.8 0.9 2.2 0.7 1.8 0.6 93.4
Hodgkin's disease 0.3 0 0.3 0 0.2 0 0.1 0 0.1 0 0.1 0 0.1 0 0.1 0 66.7
Asthma 3.9 0.6 1.1 0.2 0.7 0.2 0.6 0.2 0.6 0.2 0.5 0.2 0.5 0.2 0.5 0.2 87.2
Gallbladder disease 1.1 0.2 1 0.2 0.6 0.1 0.3 0.1 0.3 0.1 0.3 0.1 0.3 0.1 0.3 0.1 72.7
Tuberculosis 50.3 7.4 31.6 5 14.3 3.1 7.1 2 5 1.5 3.7 1.1 2.6 0.8 1.4 0.4 97.2
Hernia 0.3 0 0.2 0 0.1 0 0 0 0 0 0 0 0 0 0 0 100
Appendicitis 0.4 0.1 0.3 0 0.2 0 0.1 0 0 0 0 0 0 0 0 0 100
“Avoidable” causes 573.6 84.7 555.7 88.3 391.1 84.7 288.4 79.6 255.9 75.3 219.2 67.8 213.9 64.4 195.6 62 65.9
Deaths amenable to
medical care
440.2 65.0 405.9 64.5 249.9 54.1 151.6 41.9 129.1 38.0 104.8 32.4 105 31.6 94.1 29.8 78.6
Deaths amenable to
public health
133.4 19.7 149.8 23.8 141.2 30.6 136.8 37.8 126.8 37.3 114.4 35.4 108.9 32.8 101.5 32.2 23.9
Other causes 103.8 15.3 73.8 11.7 70.6 15.3 73.8 20.4 83.9 24.7 104.2 32.2 118.5 35.6 120 38 -15.6
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percentage terms, was dramatic. From 9.2 per 100,000
(1.5% of all deaths) in 1971, the number jumped 109.8%
to 19.3 per 100,000 (or 14.7% of all deaths). SEYLL as a
result of breast cancer increased 2.5-fold, from 263.5 in
1971 to 659.3 in 2008.
Other gender-specific AM and gender disparities in AM
Among types of mortality specific to women, almost all
ASMRs fell from 1971 to 2008. Cervical cancer declined
from 9.5 per 100,000 (1.6% of all deaths) in 1971-1975
to 4.4 per 100,000 (3.4% of all deaths) for a reduction of
53.7% by 2006-2008. Maternal mortality dropped as well,
by nearly 95.2%, from 2.1 per 100,000 (0.4% of all
deaths) to 0.1 per 100,000 (or 0.1% of all deaths). Uterine
cancer fell 85.3%, from 11.6 per 100,000 (1.9% of all
deaths) to 1.7 per 100,000 (1.3% of all deaths). AM from
some diseases (such as cervical cancer) experienced
drops in ASMRs but grew as a percentage of all deaths
because deaths from other diseases fell more quickly.
Gender disparities exist in the relative reductions both
in AM and in other deaths. In the study period, AM
reductions were greater among women (80.8%) than
among men (65.9%) in the aggregate, but also for both
AM amenable to medical care (87.7% for women vs.
78.6% reduction for men) and AM amenable to public
health interventions (28% for women vs. 23.9% reduction
for men). While deaths from other causes fell by 59.8%for women, among men such deaths increased by 15.6%.
Aggregate SEYLL from AM dropped both for men and
women, respectively from 14,878.4 and 15,609.9 in 1971
to 5,772.1 and 3,531.1 in 2008, again showing greater
improvements for women than for men.
Discussion
Our study findings show an encouraging downward
trend in most types of AM and their associated SEYLL
rates from 1971 to 2008 in Taiwan. As in many rapidly
developing countries, the mortality burden shifted from
infectious to chronic diseases. The spectacular reduction
in deaths due to tuberculosis followed both the introduc-
tion of an effective treatment for the disease (isoniazid)
[41] and a mass Bacille Calmette-Guerin vaccination pro-
gram [42]. Among chronic illnesses, the most impressive
reductions in ASMRs occurred for deaths due to hyper-
tension and cerebrovascular diseases between 1976-1980
and 1986-1990. During this period, hypertension and cere-
brovascular ASMR for males fell by 81.4%, from 319.9
per 100,000 in 1976-1980 to 59.4 per 100,000 in 1986-
1990. It dropped by almost 93.7% for women, from
345.1 per 100,000 to 21.7 per 100,000. Between 1976
and 1990, SEYLL rates from hypertension and cerebro-
vascular diseases declined by 47.6% among men and by
61.3% among women.
Prior research suggests that the dramatic reduction in
hypertension-related deaths during this period was a
Table 3 All-cause mortality under 65 years and “avoidable” mortality in Taiwan from 1971 to 2008, females
Cause 1971~1975 1976~1980 1981~1985 1986~1990 1991~1995 1996~2000 2001~2005 2006~2008 %
changeASMR % ASMR % ASMR % ASMR % ASMR % ASMR % ASMR % ASMR %
All causes 596 100 539.2 100 372 100 219.1 100 173.2 100 156.3 100 146.7 100 130.9 100 78
Injuries 40.1 6.7 44.3 8.2 41.5 11.2 38.6 17.6 34.3 19.8 30.1 19.3 24.6 16.8 21.7 16.6 45.9
Breast cancer 9.2 1.5 10.3 1.9 9.6 2.6 10.9 5 13.2 7.6 15.6 10 18.9 12.9 19.3 14.7 -109.8
Lung cancer 20.3 3.4 23 4.3 19.9 5.3 17.1 7.8 17 9.8 18.4 11.8 21.6 14.7 21.8 16.7 -7.4




345.1 57.9 341.8 63.4 210 56.5 84.4 38.5 48.3 27.9 32.5 20.8 28 19.1 21.7 16.6 93.7
Cervical cancer 9.5 1.6 10.2 1.9 8.7 2.3 7.7 3.5 8.1 4.7 7.1 4.5 6.1 4.2 4.4 3.4 53.7
Hodgkin's disease 0.2 0 0.1 0 0.1 0 0.1 0 0 0 0 0 0 0 0 0 100
Ulcers 15.7 2.6 10.1 1.9 5.6 1.5 1.4 0.6 0.9 0.5 0.7 0.4 0.7 0.5 0.5 0.4 96.8
Asthma 5.4 0.9 1.4 0.3 0.7 0.2 0.5 0.2 0.4 0.2 0.4 0.3 0.3 0.2 0.2 0.2 96.3
Gallbladder disease 1.7 0.3 1.6 0.3 0.7 0.2 0.3 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 88.2
Maternal mortality 2.1 0.4 1.3 0.2 0.7 0.2 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 95.2
Tuberculosis 25.4 4.3 14 2.6 6.1 1.6 2.4 1.1 1.4 0.8 1.1 0.7 0.6 0.4 0.3 0.2 98.8
Hernia 0.1 0 0.1 0 0.1 0 0 0 0 0 0 0 0 0 0 0 100
Uterine cancer 11.6 1.9 9.9 1.8 6 1.6 2.9 1.3 1.6 0.9 1.1 0.7 1.5 1 1.7 1.3 85.3
Appendicitis 0.6 0.1 0.4 0.1 0.2 0.1 0.1 0 0 0 0 0 0 0 0 0 100
“Avoidable” causes 518.3 87 508.6 94.3 339 91.1 183.7 83.8 138.1 79.7 116.4 74.5 111.8 76.2 99.7 76.2 80.8
Deaths amenable to
medical care
457.9 76.8 441.3 81.8 277.6 74.6 128 58.4 86.8 50.1 67.9 43.4 65.6 44.7 56.2 42.9 87.7
Deaths amenable to
public health
60.4 10.1 67.3 12.5 61.4 16.5 55.7 25.4 51.3 29.6 48.5 31.0 46.2 31.5 43.5 33.2 28.0
Other causes 77.7 13 30.6 5.7 33 8.9 35.4 16.2 35.1 20.3 39.9 25.5 34.9 23.8 31.2 23.8 59.8
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Deaths from stroke, a cerebrovascular disease, fell rap-
idly from 1982 because of the reduction in the case-
fatality rate of hemorrhagic stroke (HS), which was three
to four times higher than the case-fatality rate of cere-
bral infarction (CI) during this period [43]. Despite a
lower prevalence of HS (35.5% of acute strokes in
Taiwan) relative to CI, it constituted 60.1% of all fatal
strokes [43]. Hypertension was the most significant risk
factor for virtually all episodes of acute stroke, and was
most frequently associated with patients with HS. On
the other hand, CI was more frequent among patients
with comorbidities such as diabetes mellitus, cardiac
disease and hyperlipidemia. The combination of rapidly
decreasing HS case-fatality rates (through the anti-
hypertension campaign), and a relative increase in CI to
HS since 1982 together appear to explain much of the
reduction in AM due to hypertension and cerebrovascu-
lar diseases in the 1980s.
To verify whether the impressive reductions in AM
from hypertension and cerebrovascular diseases from
1971 to 1990 resulted from changes in coding within the
National Death Certificate Registry, we searched theliterature on the quality of death certificate coding in
Taiwan. A study of 5,621 random sample (5%) of total
deaths in 1994 showed a high level of agreement be-
tween the original coders and the reviewers, with 14.85%
and 29.20% false positive for deaths due to cerebrovascu-
lar diseases and hypertension-related diseases, and 0.85%
and 0.4% false negative [24]. The relatively high false
positive figures signify that as of 1994, reductions in
hypertension- and cerebrovascular AM may well have
been underestimated. The literature search yielded no
major systematic changes in coding procedure in Taiwan
until the late 1990s, when the Department of Health
initiated an evaluation of the quality of cause-of-death
reporting by certifying physicians and the quality of the
coding procedure [44]. Without systematic coding pro-
cedure changes for these two disease categories between
1971 and 1990, random variations in coding procedures
alone are unlikely to result in the impressive fall in AM
in this period.
Another important cause of deaths that witnessed sig-
nificant declines since 1971 is mortality from accidental
injuries. This trend is particularly prominent among
men. Male ASMRs for injuries hovered around 100-110
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until they fell to 94.5 in the 1991-1995. A similar pattern
is seen among women. Until 1986-1990, deaths from ac-
cidental injuries remained around 40 per 100,000. Then,
in 1991-1995, the figure fell to 34.3 per 100,000. SEYLL
associated with injuries varied by approximately 100
from year to year, until it dropped by 345.69 in 1997 for
men. For women, the changes were less dramatic, but
SEYLL variations hovered between the single digits and
100 in the 1990s until a drop of 132 in 1996 and 110 in
1997. During this period, large numbers of the Taiwanese
relied on motorcycles as their primary means of transpor-
tation. Traffic injuries also represented the primary cause
of death for accidental injuries [39]. The sharp drop in
SEYLL in 1997, in particular for males, coincided with
implementation of a mandatory motorcycle helmet law,
which may have been a contributing factor to the reduc-
tion in AM from injuries during the study period [36]. A
study of the 1997 law showed that motorcycle fatalities
decreased by 14% post-implementation of the safety
legislation [45].
Areas for further medical and public health investment to
reduce AM
Potential reasons for AM increases from lung and breast
cancers
We now return to the two causes of death that rose
from 1971 to 2008 – lung cancer (for both men and
women) and breast cancer (for women). Globally, can-
cer of the lung is overwhelmingly caused by tobacco
smoking [46-51]. Once diagnosed, it has an overall five-
year survival rate of only 16.3% according to U.S. esti-
mates [52], and 21.3% and 23.6% for men and women
respectively in Taiwan [53]. The prevalence of cigarette
smoking in Taiwan rose dramatically since the Second
World War [54]. By 2001, the estimated prevalence of
adult smokers was 46.8% for males and 4.3% and fe-
males [55]. The male-to-female ratio of smokers was
markedly lower for adolescents at 14.3% to 4.0% [55],
signifying that differences between male and female
lung cancer mortality rates may further narrow in the
future. Because no effective medical treatment exists
for lung cancer once diagnosed, public health measures,
particular tobacco control, may be the best policy to
counter the rise in lung cancer-related AM in Taiwan
[15,27,35,56,57].
As opposed to lung cancer, breast cancer is much
more amenable to medical care through screening, sur-
gery, radiation therapy and chemotherapy. If detected
sufficiently early (stage 0), breast cancer has a 5-year
survival rate of 93%, which decreases to 88%, 81%, 74%,
67%, 41%, 49%, and 15% as the disease progresses to
stages I, IIA, IIB, IIIA, IIIB, IIIC, and IV [58]. Among
Taiwanese women, the overall 5-year survival rate is80.4%, and 95.7%, 93.9%, 88.5%, 65%, and 18.5% respect-
ively for stages 0, I, II, III and IV [59].
The increase in AM from breast cancer may represent
a missed opportunity in Taiwan. The literature generally
substantiates better survival rates for breast cancer
among Asian women than among Caucasian women
[60,61]. Taiwan is also considered a low-incidence area
for breast cancer [62]. Estimated age-adjusted incidence
was 15-20 per 100,000 in Taiwan in 1993-1994 [62], rela-
tive to 60-90 per 100,000 in the United Kingdom and
the United States in 1985 [57]. Moreover, mortality rates
from breast cancer remain lower in Taiwan than in the
United States. In 2006-2008, the ASMR for breast cancer
was 19.3 per 100,000 in Taiwan (See Table 3), but 22.4
and 31.6 per 100,000 among white and black women re-
spectively in the United States based on data from 2005-
2009 [63].
Yet despite lower incidence and mortality rates in
Taiwan, ASMRs for breast cancer grew by 23.7% be-
tween in 1996 and 2008 even as these rates have de-
clined steadily by 2.0% per year among women in the
United States (2.1% among white women and 1.4% per
year among black women) between 1999 and 2008 [64].
A combination of lifestyle changes, advances in therapy
(adjuvant systemic therapy), earlier detection of palpable
tumors, as well as mammography screening have been
credited for the decline in breast cancer ASMRs in the
United States and other developed countries [65]. It is
possible that the higher rates of breast cancer ASMR in
Taiwan may be due to increased testing and more accur-
ate cause-of-death coding in recent years. Because the
benefits of interventions to detect and treat breast can-
cer in the early stages may not be appreciated for many
years, close monitoring of temporal trends in AM for
this disease should continue in Taiwan. More aggressive
strategies to detect and treat breast cancer in its earlier
stages, particularly among women with the highest risk,
may be warranted if reversals in the increases in breast
cancer deaths do not occur.
Gender disparities in ASMR
In virtually all non-gender-specific causes of death, there
is a clear pattern of gender disparities in ASMRs at base-
line and in the reduction in or increase in ASMRs over
time. In the 38-year period, all-cause mortality rates de-
creased by 53.4%, avoidable causes, by 62.0%, and other
causes increased by 15.6% among men. During the same
period, these three figures fell respectively by 78.0%,
80.8%, and 59.8% for women. For the four leading non-
gender-specific causes of avoidable deaths (injuries,
hypertension/cerebrovascular disease, lung cancer and
ischemic heart disease), ASMRs were (a) already lower
among women at baseline and decreased more among
women over the years (injuries), (b) roughly equal at
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death rates (cerebrovascular and heart disease), or (c) in-
creased at a slower rate than men (lung cancer) over the
38-year period. These results are broadly consistent with
findings of higher male than female mortality rates in
developed countries [66].
With respect to the gender differences in ASMRs for
cerebrovascular diseases, the result is particularly inter-
esting in light of numerous reports of more severe func-
tional outcomes and incidence of stroke among women
[38,67,68]. Part of the reason may be that women tend
to suffer from strokes and other cerebrovascular disease
at an older age than men [67], and we specifically lim-
ited our analysis of ASMRs to deaths of those aged 65
and under. Future research should investigate whether
this gender disparity in cerebrovascular mortality holds
for a more elderly portion of the Taiwanese population.Conclusion
We found impressive reductions in AM and SEYLL in
Taiwan from 1971 to 2008, particularly for deaths due to
injuries and hypertension- and cerebrovascular-related
diseases. Effective traffic safety legislation in 1997 and a
successful anti-hypertension campaign in the 1980s may
be partially credited for these successes. Nevertheless,
the study also identified two notable exceptions to the
falling AM trends in Taiwan – lung cancer among both
men and women, and breast cancer among women. The
increase in lung cancer mortality rates is likely due to
the rising prevalence of smokers in Taiwan, and to the
lack of effective medical treatment for lung cancer once
detected. The increase in breast cancer ASMRs, however,
may represent a missed opportunity for Taiwan to reduce
mortality from this particular form of cancer among
women, particularly if such trends do not reverse in the
near future.Limitations and future research
When interpreting the results of this study, a few factors
must be considered. First, despite Taiwan’s household
registration system and an associated vital statistics data
repository (death certification registry) that are consid-
ered excellent, coding errors do occur [24,69]. However,
to alter the basic conclusions of this study, there would
have had to be systematic undercoding in the latter years
of AM that experienced reductions in ASMRs, and
systematic overcoding of AM that witnessed increases.
Second, despite Taiwan’s implementation of National
Health Insurance (NHI) in 1996, a visual inspection of
the AM trend lines suggests that NHI did not noticeably
reduce amenable deaths at the aggregate population
level. Future research should consider the potential dif-
ferential impact of insurance coverage expansion onvulnerable populations such as the indigent, the elderly,
and ethnic minorities.
Given the increase in life expectancy in Taiwan, future
research should also consider raising the ASMRs to age
75. Likewise, to identify potential differential impacts of
increased access to care, disease-specific studies should
be conducted by dividing the study sample into groups
that were already covered under the old patchwork of
insurance plans and those who were newly insured in
1996. Geographic variations, as well as socioeconomic
differences in AM ASMRs should also be studied, since
any potential positive impact of the NHI may be
masked in an aggregate analysis such as ours. Finally,
the underlying mechanisms differentiating the gender
differences in ASMR trends should also be studied, as
they may offer important policy insight to improve the
public’s health.
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